CLINICAL TRIALS PROFILE FOR LAMZEDE
✉ Email this page to a colleague
All Clinical Trials for LAMZEDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01908712 ↗ | Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients | Enrolling by invitation | Chiesi Farmaceutici S.p.A. | Phase 3 | 2013-08-01 | The overall objective of this trial is to provide aftercare treatment with Lamazym and to evaluate the safety of repeated Lamzede i.v. treatment of subjects with alpha-Mannosidosis. |
NCT01908712 ↗ | Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients | Enrolling by invitation | Zymenex A/S | Phase 3 | 2013-08-01 | The overall objective of this trial is to provide aftercare treatment with Lamazym and to evaluate the safety of repeated Lamzede i.v. treatment of subjects with alpha-Mannosidosis. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LAMZEDE
Condition Name
Clinical Trial Locations for LAMZEDE
Clinical Trial Progress for LAMZEDE
Clinical Trial Phase
Clinical Trial Sponsors for LAMZEDE
Sponsor Name